
Vip Patel
Examiner (ID: 11268, Phone: (571)272-2458 , Office: P/2879 )
| Most Active Art Unit | 2879 |
| Art Unit(s) | 2215, 3621, 2889, 2604, 2875, 2618, 2879 |
| Total Applications | 2443 |
| Issued Applications | 2199 |
| Pending Applications | 38 |
| Abandoned Applications | 210 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4291512
[patent_doc_number] => 06197504
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-06
[patent_title] => 'Method of detecting expression of MAB-21'
[patent_app_type] => 1
[patent_app_number] => 9/008697
[patent_app_country] => US
[patent_app_date] => 1998-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 47
[patent_no_of_words] => 17397
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/197/06197504.pdf
[firstpage_image] =>[orig_patent_app_number] => 008697
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/008697 | Method of detecting expression of MAB-21 | Jan 18, 1998 | Issued |
| 08/995060 | PURIFIED EUKARYOTIC- INITIATION FACTOR 4E | Dec 18, 1997 | Abandoned |
Array
(
[id] => 3975907
[patent_doc_number] => 05958423
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-28
[patent_title] => 'Modified live BRSV vaccine'
[patent_app_type] => 1
[patent_app_number] => 8/993400
[patent_app_country] => US
[patent_app_date] => 1997-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4249
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/958/05958423.pdf
[firstpage_image] =>[orig_patent_app_number] => 993400
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/993400 | Modified live BRSV vaccine | Dec 17, 1997 | Issued |
Array
(
[id] => 4407553
[patent_doc_number] => 06309878
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-30
[patent_title] => 'Glucose-inducible recombinant viral vector'
[patent_app_type] => 1
[patent_app_number] => 8/945140
[patent_app_country] => US
[patent_app_date] => 1997-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7007
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/309/06309878.pdf
[firstpage_image] =>[orig_patent_app_number] => 945140
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/945140 | Glucose-inducible recombinant viral vector | Dec 16, 1997 | Issued |
Array
(
[id] => 4188548
[patent_doc_number] => 06093795
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-25
[patent_title] => 'Isolated human Prt1 protein'
[patent_app_type] => 1
[patent_app_number] => 8/990140
[patent_app_country] => US
[patent_app_date] => 1997-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 28855
[patent_no_of_claims] => 151
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/093/06093795.pdf
[firstpage_image] =>[orig_patent_app_number] => 990140
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/990140 | Isolated human Prt1 protein | Dec 11, 1997 | Issued |
Array
(
[id] => 4297800
[patent_doc_number] => 06184343
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-06
[patent_title] => 'Fetal globin inducing factor'
[patent_app_type] => 1
[patent_app_number] => 8/986304
[patent_app_country] => US
[patent_app_date] => 1997-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 5
[patent_no_of_words] => 6226
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/184/06184343.pdf
[firstpage_image] =>[orig_patent_app_number] => 986304
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/986304 | Fetal globin inducing factor | Dec 4, 1997 | Issued |
Array
(
[id] => 3981522
[patent_doc_number] => 05948883
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-07
[patent_title] => 'Human CRM1 Protein'
[patent_app_type] => 1
[patent_app_number] => 8/975527
[patent_app_country] => US
[patent_app_date] => 1997-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 18313
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/948/05948883.pdf
[firstpage_image] =>[orig_patent_app_number] => 975527
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/975527 | Human CRM1 Protein | Nov 19, 1997 | Issued |
Array
(
[id] => 4046300
[patent_doc_number] => 05968773
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-19
[patent_title] => 'System and method for regulation of gene expression'
[patent_app_type] => 1
[patent_app_number] => 8/970315
[patent_app_country] => US
[patent_app_date] => 1997-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3127
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/968/05968773.pdf
[firstpage_image] =>[orig_patent_app_number] => 970315
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/970315 | System and method for regulation of gene expression | Nov 13, 1997 | Issued |
| 08/969239 | HOQBQ59 | Nov 12, 1997 | Abandoned |
Array
(
[id] => 3931673
[patent_doc_number] => 05928908
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-27
[patent_title] => 'Method for introducing unidirectional nested deletions'
[patent_app_type] => 1
[patent_app_number] => 8/966958
[patent_app_country] => US
[patent_app_date] => 1997-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3656
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/928/05928908.pdf
[firstpage_image] =>[orig_patent_app_number] => 966958
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/966958 | Method for introducing unidirectional nested deletions | Nov 9, 1997 | Issued |
Array
(
[id] => 3763671
[patent_doc_number] => 05844082
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-01
[patent_title] => 'Human acute phase response factor'
[patent_app_type] => 1
[patent_app_number] => 8/965462
[patent_app_country] => US
[patent_app_date] => 1997-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6447
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/844/05844082.pdf
[firstpage_image] =>[orig_patent_app_number] => 965462
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/965462 | Human acute phase response factor | Nov 5, 1997 | Issued |
Array
(
[id] => 5829149
[patent_doc_number] => 20020068690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-06
[patent_title] => 'USE OF NF-KB INHIBITION IN COMBINATION THERAPY FOR CANCER'
[patent_app_type] => new
[patent_app_number] => 08/959160
[patent_app_country] => US
[patent_app_date] => 1997-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8646
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20020068690.pdf
[firstpage_image] =>[orig_patent_app_number] => 08959160
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/959160 | Use of NF-B inhibition in combination therapy for cancer | Oct 27, 1997 | Issued |
| 08/955900 | TEMPERATURE SENSITIVE CLUSTERED CHARGED-TO-ALANINE MUTANTS OF INFLUENZA VIRUS PB2 GENE | Oct 21, 1997 | Abandoned |
Array
(
[id] => 4420392
[patent_doc_number] => 06177403
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-23
[patent_title] => 'Compositions, methods, and apparatus for delivery of a macromolecular assembly to an extravascular tissue of an animal'
[patent_app_type] => 1
[patent_app_number] => 8/954815
[patent_app_country] => US
[patent_app_date] => 1997-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 21
[patent_no_of_words] => 15760
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/177/06177403.pdf
[firstpage_image] =>[orig_patent_app_number] => 954815
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/954815 | Compositions, methods, and apparatus for delivery of a macromolecular assembly to an extravascular tissue of an animal | Oct 20, 1997 | Issued |
Array
(
[id] => 3931510
[patent_doc_number] => 05928897
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-27
[patent_title] => 'Expression of a gram-positive bacteria replicon'
[patent_app_type] => 1
[patent_app_number] => 8/955091
[patent_app_country] => US
[patent_app_date] => 1997-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 14
[patent_no_of_words] => 16611
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/928/05928897.pdf
[firstpage_image] =>[orig_patent_app_number] => 955091
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/955091 | Expression of a gram-positive bacteria replicon | Oct 20, 1997 | Issued |
Array
(
[id] => 3768253
[patent_doc_number] => 05849581
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-15
[patent_title] => 'Regulators of UCP3 gene expression'
[patent_app_type] => 1
[patent_app_number] => 8/948277
[patent_app_country] => US
[patent_app_date] => 1997-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3488
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/849/05849581.pdf
[firstpage_image] =>[orig_patent_app_number] => 948277
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/948277 | Regulators of UCP3 gene expression | Oct 8, 1997 | Issued |
Array
(
[id] => 3932169
[patent_doc_number] => 05928941
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-27
[patent_title] => 'Repressor kruppel-like factor'
[patent_app_type] => 1
[patent_app_number] => 8/946241
[patent_app_country] => US
[patent_app_date] => 1997-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 8711
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/928/05928941.pdf
[firstpage_image] =>[orig_patent_app_number] => 946241
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/946241 | Repressor kruppel-like factor | Oct 6, 1997 | Issued |
Array
(
[id] => 4018484
[patent_doc_number] => 05906935
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-05-25
[patent_title] => 'Cells transformed or transfected with HCMV US2-US5, US10-US11 genes'
[patent_app_type] => 1
[patent_app_number] => 8/946598
[patent_app_country] => US
[patent_app_date] => 1997-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 39
[patent_no_of_words] => 9262
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/906/05906935.pdf
[firstpage_image] =>[orig_patent_app_number] => 946598
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/946598 | Cells transformed or transfected with HCMV US2-US5, US10-US11 genes | Oct 6, 1997 | Issued |
Array
(
[id] => 4180556
[patent_doc_number] => 06020194
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-01
[patent_title] => 'DNA encoding a Myt1 polypeptide'
[patent_app_type] => 1
[patent_app_number] => 8/942001
[patent_app_country] => US
[patent_app_date] => 1997-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 15
[patent_no_of_words] => 17061
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/020/06020194.pdf
[firstpage_image] =>[orig_patent_app_number] => 942001
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/942001 | DNA encoding a Myt1 polypeptide | Sep 30, 1997 | Issued |
Array
(
[id] => 4180003
[patent_doc_number] => 06020160
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-01
[patent_title] => 'RsbV-1 polynucleotides of Staphylococcus aureus'
[patent_app_type] => 1
[patent_app_number] => 8/938716
[patent_app_country] => US
[patent_app_date] => 1997-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 0
[patent_no_of_words] => 14928
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/020/06020160.pdf
[firstpage_image] =>[orig_patent_app_number] => 938716
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/938716 | RsbV-1 polynucleotides of Staphylococcus aureus | Sep 25, 1997 | Issued |